Evaluation of the efficacy of Tetonal drug in comparison with Meloxicam on pain relief and functional improvent of patient with knee osteoartheritis

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

IRCT

Registry ID

IRCT20191031045291N1

Enrollment

Registered

2020-01-26

Start date

2019-12-07

Completion date

Unknown

Last updated

2020-02-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Knee osteoartheritis.

Interventions

Intervention 1: Intervention group 1: Meloxicam from Iran Daroo company ,15 mg daily for 10 days. Intervention 2: Intervention group 2: daily use of two tablets of Telnonal from Razak Company for one

Eligibility

Sex/Gender

All

Age

40 Years to 70 Years

Inclusion criteria

Inclusion criteria: Adult patient aged 40-70 Clinical diagnosis of osteoarthritis Patient had been symptomatic for one month No periarticular disease

Exclusion criteria

Exclusion criteria: Collagen vascular disease Radiculopathy Brucella Knee truma Bmi >42 Bleeding tendency History of drug reaction

Design outcomes

Primary

Measure	Time frame
Knee pain. Timepoint: Before the intervention, the second, fourth and eighth weeks after the intervention. Method of measurement: visual analogue scale (VAS) score, estern Ontario and McMaster Universities Osteoarthritis Index(WOMAC ) and Oxford Knee Score (OKS) questionnaires.;Knee function. Timepoint: Before the intervention, the second, fourth and eighth weeks after the intervention. Method of measurement: visual analogue scale (VAS) score, estern Ontario and McMaster Universities Osteoarthritis Index(WOMAC ) and Oxford Knee Score (OKS) questionnaires.;Knee stiffness. Timepoint: Before the intervention, the second, fourth and eighth weeks after the intervention. Method of measurement: visual analogue scale (VAS) score, estern Ontario and McMaster Universities Osteoarthritis Index(WOMAC ) and Oxford Knee Score (OKS) questionnaires.	—

Measure

Time frame

Knee pain. Timepoint: Before the intervention, the second, fourth and eighth weeks after the intervention. Method of measurement: visual analogue scale (VAS) score, estern Ontario and McMaster Universities Osteoarthritis Index(WOMAC ) and Oxford Knee Score (OKS) questionnaires.;Knee function. Timepoint: Before the intervention, the second, fourth and eighth weeks after the intervention. Method of measurement: visual analogue scale (VAS) score, estern Ontario and McMaster Universities Osteoarthritis Index(WOMAC ) and Oxford Knee Score (OKS) questionnaires.;Knee stiffness. Timepoint: Before the intervention, the second, fourth and eighth weeks after the intervention. Method of measurement: visual analogue scale (VAS) score, estern Ontario and McMaster Universities Osteoarthritis Index(WOMAC ) and Oxford Knee Score (OKS) questionnaires.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactNajmeh Rajabi

Shiraz University of Medical Sciences

n.rajabi.1372@gmail.com+98 71 3230 5884

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026